Antibody-drug conjugates (ADCs) are changing the therapeutic landscape for platinum-resistant ovarian cancer (PROC), and emerging targets are poised to expand effective treatment options for a broader range of patients. Test your knowledge regarding the evolving ADC landscape in PROC in this interactive Knowledge CheckPoint activity. Receive expert feedback on your answer selections, benchmark your performance against peers, and download concise summaries of supporting evidence. Strengthen your understanding of next-generation ADC mechanisms, safety and efficacy data, and practice implications to optimize care for patients with PROC.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 360 Park Avenue South
Pricing
99% of listed courses are free
298 of a sample of 300 are free · 416 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Interventional Radiology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Musculoskeletal Oncology
- Nephrology
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Neurology
- Practice Management & Ethics
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Urological Oncology
- Urology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 0.25 credits
- Commercial Support
-
ReleasedDec 2, 2025
-
Last day to claim creditDec 2, 2026 8 weeks left
-
PRIME Education, Inc. (PRIME®) The Next Wave of ADC Innovation in Platinum-Resistant Ovarian Cancer
-
PRIME Education, Inc. (PRIME®) The Latest Evidence and Real-World Clinical Trial Enrollment Strategies in Platinum-Resistant Ovarian Cancer
-
PRIME Education, Inc. (PRIME®) Inside the ADC Pipeline: Translating Emerging Clinical Evidence Into Personalized Care for PROC
-
Global Learning Collaborative CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian Cancer
-
Learner’s Digest International (TM) Biomarkers for Antibody-Drug Conjugates in Breast Cancer
-
Physicians’ Education Resource The ADC Revolution in Metastatic Breast Cancer: Redefining Treatment Selection and Sequencing
